Chugai Pharmaceutical Co., Ltd. (CHGCY)
21.82
-0.37
(-1.67%)
USD |
OTCM |
Aug 24, 16:00
Chugai Pharmaceutical Debt to Equity Ratio : 0.0087 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0087 |
| March 31, 2026 | 0.0092 |
| December 31, 2025 | 0.0127 |
| September 30, 2025 | 0.0064 |
| June 30, 2025 | 0.0067 |
| March 31, 2025 | 0.0069 |
| December 31, 2024 | 0.0057 |
| September 30, 2024 | 0.0033 |
| June 30, 2024 | 0.0038 |
| March 31, 2024 | 0.0042 |
| December 31, 2023 | 0.0083 |
| September 30, 2023 | 0.0055 |
| June 30, 2023 | 0.005 |
| March 31, 2023 | 0.0057 |
| December 31, 2022 | 0.0099 |
| September 30, 2022 | 0.0072 |
| June 30, 2022 | 0.0071 |
| March 31, 2022 | 0.0081 |
| December 31, 2021 | 0.0135 |
| September 30, 2021 | 0.0046 |
| June 30, 2021 | 0.0045 |
| March 31, 2021 | 0.0058 |
| December 31, 2020 | 0.0115 |
| September 30, 2020 | 0.0065 |
| June 30, 2020 | 0.0052 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0069 |
| December 31, 2019 | 0.0149 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.0003 |
| September 30, 2018 | 0.0003 |
| June 30, 2018 | 0.0004 |
| March 31, 2018 | 0.0004 |
| December 31, 2017 | 0.0005 |
| September 30, 2017 | 0.0005 |
| June 30, 2017 | 0.0006 |
| March 31, 2017 | 0.0009 |
| December 31, 2016 | 0.001 |
| September 30, 2016 | 0.001 |
| June 30, 2016 | 0.0011 |
| March 31, 2016 | 0.0011 |
| December 31, 2015 | 0.0012 |
| September 30, 2015 | 0.0012 |
| June 30, 2015 | 0.0003 |
| March 31, 2015 | 0.0003 |
| December 31, 2014 | 0.0004 |
| September 30, 2014 | 0.0004 |
| June 30, 2014 | 0.0004 |
| March 31, 2014 | 0.0004 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.6536 |
| Daiichi Sankyo Co., Ltd. | 0.2939 |
| Eisai Co., Ltd. | 0.2993 |
| Santen Pharmaceutical Co., Ltd. | 0.1033 |
| Ono Pharmaceutical Co., Ltd. | 0.1351 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 15.07B |
| Total Liabilities (Quarterly) | 2.598B |
| Shareholders Equity (Quarterly) | 12.48B |
| Current Ratio | 4.345 |
| Net Debt Paydown Yield | -0.01% |